Synergy CHC (SNYR) Asset Writedowns and Impairment (2018 - 2024)

Synergy CHC's (SNYR) quarterly Asset Writedowns and Impairment came in at $120565.0 in Q4 2024, down 47.36% year-on-year from $229027.0 in Q1 2024, and up 5123.54% quarter-over-quarter from -$2400.0 in Q2 2024.

Synergy CHC (SNYR) Asset Writedowns and Impairment (2018 - 2024) Analysis & Trends

Synergy CHC's Asset Writedowns and Impairment history runs 4 years deep, the most recent figure standing at $120565.0 for Q4 2024.

  • On a quarterly basis, Asset Writedowns and Impairment fell 47.36% year-over-year to $120565.0 in Q4 2024; TTM through Dec 2024 was $125364.0, a N/A change from a year earlier, with the FY2025 full-year figure at $2.3 million, up 1700.23% from the prior year.
  • Asset Writedowns and Impairment improved to $120565.0 in Q4 2024 per SNYR's latest filing, from -$2400.0 in the prior quarter.
  • Across five years, Asset Writedowns and Impairment topped out at $229027.0 in Q4 2023 and bottomed at -$2400.0 in Q2 2024.
Generated on {Timestamp} © BusinessQuant.com
Generated on {Timestamp} Powered by BusinessQuant Logo

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Mckesson 105.15 Bn 101.18 Bn 4.04 Bn
2 Cencora 60.58 Bn 58.40 Bn 3.59 Bn
3 Cardinal Health 53.81 Bn 49.87 Bn 2.50 Bn
4 Henry Schein 9.71 Bn 9.57 Bn 1.07 Bn
5 Akso Health 3.28 Bn 3.28 Bn -
6 111 651.73 Mn 572.63 Mn 23.58 Mn
7 Accendra Health 248.02 Mn -88.86 Mn 278.03 Mn
8 Edap Tms 230.14 Mn 215.14 Mn 8.15 Mn
9 VitaNova Life Sciences 11.51 Mn 11.01 Mn 316,343.00
10 Synergy CHC 1.63 Mn -1.09 Mn 2.22 Mn

Historic Data

Download Data
DateValue
Dec 31, 2024 120,565.00
Dec 31, 2024 120,565.00
Jun 30, 2024 -2,400.00
Jun 30, 2024 -2,400.00
Mar 31, 2024 7,199.00
Mar 31, 2024 7,199.00
Dec 31, 2023 229,027.00
Dec 31, 2023 229,027.00
Dec 31, 2019 -1.92 Mn
Dec 31, 2019 -1.92 Mn
Dec 31, 2018 -924,068.00
Dec 31, 2018 -924,068.00